Project A 52-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab…

Basic data

Title:
A 52-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis
Duration:
19/10/2015 to 30/09/2018
Abstract / short description:
Klinische Studie
Keywords:
dermatology
Dermatologie
clinical trial
klinische Studie
psoriasis
Schuppenflechte

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Basingstoke, Hampshire, United Kingdom
Help

will be deleted permanently. This cannot be undone.